Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia

Signal Transduct Target Ther. 2021 Feb 26;6(1):96. doi: 10.1038/s41392-021-00514-6.

Authors

Weilin Zhou¹, Wei Wang²

Affiliations

¹ State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, People's Republic of China.
² State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, People's Republic of China. weiwang@scu.edu.cn.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Autoantibodies
COVID-19*
Humans
Interferon Type I*
SARS-CoV-2

Substances

Autoantibodies
Interferon Type I